Premier Medical Group of the Hudson Valley is proud to announce that Dr. Evan R. Goldfischer was recently appointed to Chairman of the Advanced Prostate Cancer Expert Panel by the Public Education Council of the Urology Care Foundation , The official foundation of the American Urological Association. Dr. Goldfischer serves as the Medical Director of...Read More

A team approach to the complexities of advanced PC care. As  recently as five years ago, there were very few options available for patients with advanced, metastatic prostate cancer,” says Dr. Evan R. Goldfischer, co-CEO of Premier. Today, however, the situation is much brighter. “A number of new drugs have been approved—with new mechanisms of...Read More

Promoting Wellness for Prostate Cancer Patients  Dr. Mark A. Moyad, MD, MPH (available on Amazon.com)  Many people these days are interested in holistic therapy, and just about everyone would prefer to take something “natural” rather than taking pills. When it comes to prostate cancer and prostate health, patients will ask, “What can I do doc,...Read More

More than 200,000 men will be diagnosed with prostate cancer in 2010. Those of them that need surgery will find a remarkable new tool in their surgeon’s hands. Health statistics tell us that about 1 of every 6 men will be diagnosed with prostate cancer during his lifetime. In the years since the prostate-specific antigen (PSA) test...Read More

Having an in-house pathology lab guarantees that Premier’s labwork is done promptly and efficiently—with two pathologists reviewing every “positive” specimen— so our patients won’t have to endure anxious waits to learn about the next step in their treatment. What is the major benefit of having a dedicated “in-house” pathology department? On this question, the physicians...Read More

For several months now, the prostate specific antigen (PSA ) test has been the subject of many headlines and news reports. The controversy has centered on the question of whether screening all men with the PSA test actually reduces the overall number of deaths from prostate cancer and whether the benefits of routine screening outweigh...Read More